Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬Alcoholic liver disease
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬1. Alcoholic liver disease
|
||||||||||||||||||||||||||
| 2 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Alcoholic liver disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬2. Alcoholic liver disease
|
||||||||||||||||||||||||||
| 3 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Alcoholic liver disease
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬3. Alcoholic liver disease
|
||||||||||||||||||||||||||
| 4 | Alcoholic liver disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬Alcoholic liver disease
| Tibulizumab | 051 [2] 51, 53 💬
|
||||||||||||||||||||||||||
| 5 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬Cytokine-cytokine receptor interaction
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬5. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||
| 6 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Cytokine-cytokine receptor interaction
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬6. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||
| 7 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Cytokine-cytokine receptor interaction
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬7. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||
| 8 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬Cytokine-cytokine receptor interaction
| Tibulizumab | 051 [2] 51, 53 💬
|
||||||||||||||||||||||||||
| 9 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬IL-17 signaling pathway
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬9. IL-17 signaling pathway
|
||||||||||||||||||||||||||
| 10 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬IL-17 signaling pathway
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬10. IL-17 signaling pathway
|
||||||||||||||||||||||||||
| 11 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬IL-17 signaling pathway
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬11. IL-17 signaling pathway
|
||||||||||||||||||||||||||
| 12 | IL-17 signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬IL-17 signaling pathway
| Tibulizumab | 051 [2] 51, 53 💬
|
||||||||||||||||||||||||||
| 13 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬Inflammatory bowel disease
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬13. Inflammatory bowel disease
|
||||||||||||||||||||||||||
| 14 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Inflammatory bowel disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬14. Inflammatory bowel disease
|
||||||||||||||||||||||||||
| 15 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Inflammatory bowel disease
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬15. Inflammatory bowel disease
|
||||||||||||||||||||||||||
| 16 | Inflammatory bowel disease 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬Inflammatory bowel disease
| Tibulizumab | 051 [2] 51, 53 💬
|
||||||||||||||||||||||||||
| 17 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬Rheumatoid arthritis
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬17. Rheumatoid arthritis
|
||||||||||||||||||||||||||
| 18 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Rheumatoid arthritis
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬18. Rheumatoid arthritis
|
||||||||||||||||||||||||||
| 19 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Rheumatoid arthritis
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬19. Rheumatoid arthritis
|
||||||||||||||||||||||||||
| 20 | Rheumatoid arthritis 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬Rheumatoid arthritis
| Tibulizumab | 051 [2] 51, 53 💬
|
||||||||||||||||||||||||||
| 21 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Bimekizumab Bimekizumab 💬Th17 cell differentiation
| Bimekizumab | 037 [5] 37, 46, 97, 107, 271 💬21. Th17 cell differentiation
|
||||||||||||||||||||||||||
| 22 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Th17 cell differentiation
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬22. Th17 cell differentiation
|
||||||||||||||||||||||||||
| 23 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Th17 cell differentiation
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬23. Th17 cell differentiation
|
||||||||||||||||||||||||||
| 24 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 13 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Tibulizumab Tibulizumab 💬Th17 cell differentiation
| Tibulizumab | 051 [2] 51, 53 💬
|
Alcoholic liver disease
1 gene, 4 drugs (DrugBank) and 13 diseases
Cytokine-cytokine receptor interaction
1 gene, 4 drugs (DrugBank) and 13 diseases
IL-17 signaling pathway
1 gene, 4 drugs (DrugBank) and 13 diseases
Inflammatory bowel disease
1 gene, 4 drugs (DrugBank) and 13 diseases
Rheumatoid arthritis
1 gene, 4 drugs (DrugBank) and 13 diseases
Th17 cell differentiation
1 gene, 4 drugs (DrugBank) and 13 diseases
